Published in Hepatitis Weekly, June 5th, 2006
"Although the HBx is thought to play a causative role in the development of hepatocellular carcinoma, it is not yet known whether interfering with HBx function may affect the cellular transformation of HBx-expressing tumor cells," wrote Y.H. Jin and colleagues, Ajou University. "To address this question, we adopted an intracellular antibody fragment expression approach to block the function of HBx."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.